| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |